Enzon Pharmaceuticals Up 27.2% Since SmarTrend's Buy Recommendation
ENZN | Quote | Chart | News | PowerRating -- SmarTrend, our proprietary pattern recognition system, called an Uptrend for Enzon Pharmaceuticals (NASDAQ:ENZN) on September 29, 2009 at $8.28.
Since then, Enzon Pharmaceuticals has returned 27.2% as of today's recent price of $10.53. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
For full details on Enzon Pharmaceuticals Inc (ENZN) ENZN. Enzon Pharmaceuticals Inc (ENZN) has Short Term PowerRatings at TradingMarkets. Details on Enzon Pharmaceuticals Inc (ENZN) Short Term PowerRatings is available at This Link.
- Enzon Pharmaceuticals Inc. (ENZN) Corporate Event Announcement Notice - 02/09/10
- CORRECTING and REPLACING Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webc - 02/09/10
- Enzon to Release Fourth Quarter 2009 Earnings on Wednesday, February 17, 2010; Conference Call and Webcast to Follow - 02/09/10
- Enzon Pharmaceuticals: The Trend Continues Down (ENZN) - 02/05/10
- SmarTrend's Candlestick Scanner Detects Bearish Engulfing Pattern for Enzon Pharmaceuticals (ENZN) - 02/02/10
- More News >>


